GNTA — Genenta Science SpA Balance Sheet
0.000.00%
- $145.22m
- $130.92m
- 28
- 14
- 52
- 22
Annual balance sheet for Genenta Science SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 15.5 | 37.2 | 29.8 | 18.8 | 12.7 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.761 | 1.48 | 1.6 | 2.04 | 1.48 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 16.5 | 38.8 | 31.7 | 21.3 | 14.5 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.019 | 0.023 | 0.112 | 0.083 | 0.043 |
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 17.5 | 40 | 33.4 | 22.3 | 14.8 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 2.33 | 1.14 | 2.18 | 1.74 | 2.1 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.35 | 1.17 | 2.3 | 1.91 | 2.33 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 15.2 | 38.9 | 31.1 | 20.4 | 12.5 |
Total Liabilities & Shareholders' Equity | 17.5 | 40 | 33.4 | 22.3 | 14.8 |
Total Common Shares Outstanding |